Physician profile
Jonathan E Scholl
NPI 1467907253
$11,130.95
in general payments reported to CMS, 2019-2025
16 companies · $1,779 in 2025
The $1,779 reported for 2025 was more than what 75% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,974 · 2020: $610 · 2021: $816 · 2022: $1,413 · 2023: $1,958 · 2024: $1,581 · 2025: $1,779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,038 · Travel and Lodging: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,038.41 |
| Travel and Lodging | $278.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,979.57 | 2019-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $3,023.40 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Medtronic, INC. | $1,490.11 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Endurant Iis |
| Si-Bone, INC. | $493.93 | 2019-2025 | |
| Averitas Pharma INC. | $435.94 | 2023-2025 | Qutenza |
| Grt US Holding, INC. | $159.90 | 2022 | |
| Mml US, INC. | $138.71 | 2022 | |
| Medtronic USA, INC. | $90.93 | 2019-2020 | |
| Curonix LLC | $90.59 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nevro Corp. | $53.48 | 2021-2024 | Senza |
| Collegium Pharmaceutical, INC. | $43.99 | 2023-2025 | Belbuca, Xtampza |
| Spr Therapeutics, INC | $38.55 | 2023-2025 | Sprint Pns System |
| Lundbeck LLC | $32.75 | 2025 | Vyepti |
| Virtus Pharmaceuticals LLC | $23.81 | 2025 | Levorphanol Tartrate |
| Vertex Pharmaceuticals Incorporated | $18.75 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electronic Waveform Lab, INC. | $16.54 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Scholl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.